Mutational analysis and clinical correlation of metastatic colorectal cancer

E-ISSN： 1097-0142|120|10|1482-1490

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.10, 2014-05, pp. : 1482-1490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical and Economic Aspects of KRAS Mutational Status as Predictor for Epidermal Growth Factor Receptor Inhibitor Therapy in Metastatic Colorectal Cancer Patients

Oncology, Vol. 81, Iss. 5-6, 2012-01 ,pp. : 359-364

Karger

Access to resources Recommend Favorite

Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status

Oncology, Vol. 77, Iss. 5, 2009-11 ,pp. : 293-299

Karger

Access to resources Recommend Favorite

Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-02 ,pp. : 83-87

Karger

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of First-Line Chemotherapies in Metastatic Colorectal Cancer

Oncology, Vol. 71, Iss. 1-2, 2007-04 ,pp. : 40-48

Karger

Access to resources Recommend Favorite

The Role of UFT in Metastatic Colorectal Cancer

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 301-310

Karger

Access to resources Recommend Favorite